Cramer's lightning round: Editas Medicine is not a buy

• Jim Cramer is once again answering callers' stock questions at a rapid pace, as indicated by the ringing of the lightning round bell on "Mad Money."

The battle for market share is ongoing, with no indication of an end in sight. However, I believe they will ultimately emerge victorious.

I can't advise you to sell it, but I can also say that I may not be the solution for this stock because it has been going down in price for a long time and I thought it would stop.

It's not possible to purchase growth stocks that lack the potential to generate profits in this market.

Tobacco is not something I enjoy, but if you don't mind, that's okay.

Join the CNBC Investing Club to receive updates on Jim Cramer's market moves.